The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-11), Indo US Bio-Tech's share price is ₹87.52.
Indo US Bio-Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹6.54. Therefore, Indo US Bio-Tech's PE Ratio for today is 13.38.
Good Sign:
Indo US Bio-Tech Ltd stock PE Ratio (=13.67) is close to 5-year low of 13.56.
During the past 13 years, Indo US Bio-Tech's highest PE Ratio was 74.69. The lowest was 13.11. And the median was 35.42.
Indo US Bio-Tech's EPS (Diluted) for the
three
months ended in Mar. 2026 was ₹0.98.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹6.54.
During the past 12 months, Indo US Bio-Tech's average EPS without NRIGrowth Rate was -19.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 21.90% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 16.40% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 37.90% per year.
During the past 13 years, Indo US Bio-Tech's highest 3-Year average EPS without NRI Growth Rate was 82.10% per year. The lowest was 3.60% per year. And the median was 27.10% per year.
Indo US Bio-Tech's EPS (Basic) for the
three
months ended in Mar. 2026 was ₹0.98.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹6.54.
Back to Basics: PE Ratio
Indo US Bio-Tech (NSE:INDOUS) PE Ratio Explanation
The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.
If a company loses money, the PE Ratio becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.
Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.
PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.
Indo US Bio-Tech PE Ratio Related Terms
Indo US Bio-Tech PE Ratio Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Indo US Bio-Tech's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech PE Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's PE Ratio distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's PE Ratio falls into.
The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Indo US Bio-Tech's Share Price of today is ₹87.52. Indo US Bio-Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Indo US Bio-Tech (NSE:INDOUS) has a PE Ratio of 13.38 as of Jul. 11, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Indo US Bio-Tech and its competitors. This is 62% below median its historical median of 35.42. Over the past decade, Indo US Bio-Tech's PE Ratio has ranged from 13.11 to 74.69.
Is Indo US Bio-Tech's PE Ratio too high?
Indo US Bio-Tech's current PE Ratio of 13.38 is 62% below median its 10-year median of 35.42. Over the past 10 years, this metric has ranged from a low of 13.11 to a high of 74.69. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's PE Ratio compare to CTVA and CF?
Indo US Bio-Tech's PE Ratio of 13.38 can be compared against companies in the Agriculture industry. Historically, Indo US Bio-Tech's own PE Ratio has ranged from 13.11 to 74.69 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for an Agriculture company?
A good PE Ratio depends on the Agriculture industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Indo US Bio-Tech and its competitors. Indo US Bio-Tech's current PE Ratio is 13.38, which is 62% below median its own 10-year median of 35.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹312.23, compared to a current price of ₹87.52 — trading 72% below its estimated fair value. The current PE Ratio is 13.38, which is 62% below median its 10-year median of 35.42. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current PE Ratio is 13.38 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹87.52 is trading 72% below its estimated GF Value™ of ₹312.23.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
PE Ratio: 13.38 (62% below median its 10-year median of 35.42)
GF Value™: ₹312.23 vs. price of ₹87.52 (72% below fair value)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
